期刊文献+

过表达HSP20的慢病毒载体对H_2O_2诱导的大鼠心肌细胞凋亡的影响 被引量:3

Effect of the lentiviral vector overexpressing HSP20 on the myocardial apoptosis induced by H_2O_2
下载PDF
导出
摘要 目的构建过表达大鼠热休克蛋白20(HSP20)基因慢病毒载体,探讨其对H2O2诱导的大鼠H9C2心肌细胞凋亡的影响。方法构建大鼠HSP20基因pHIV-HSP20过表达质粒慢病毒,与包装质粒psPAX2、pMD2G共转染293FT细胞,检测其转染效率;包装慢病毒并转染H9C2心肌细胞;72 h后观察其转染效率,RT-PCR法检测细胞HSP20 mRNA表达,CCK-8、Hochest33258染色法检测H2O2诱导后H9C2心肌细胞凋亡情况。结果成功构建了HSP20慢病毒过表达载体,经293FT细胞包装后,其对H9C2细胞72 h的转染效率为95%;与慢性病毒组比较,H9C2细胞转染72 h后HSP20 mRNA水平显著升高,细胞活力下降,心肌细胞凋亡率明显降低(P均<0.01)。结论过表达HSP20能显著抑制H2O2诱导的H9C2心肌细胞凋亡。 Objective To construct the lentiviral vector overexpressing heat shock protein 20 ( HSP20), and to investigate its effect on the apoptosis of myocardial H9C2 Cells induced by H2O2. Methods The lentiviral vector (pHIV) was constructed by inserting the lentiviral vectors with the HSP20 gene fragment. The recombination lentiviral particles were produced by the packaging 293T cell, then the transduction efficiency was detected. H9C2 cells were infected with recom- binant lentivirus overexpressing HSP20, and the expression level of HSP20 in cells was examined by the RT-PCR 72 hs lat- er. The H2O2 induced apoptosis in H9C2 cells was investigated by CCK-8 assay and Hoechst33258 staining method. Results pHIV-HSP20 lentivirus was constructed successfully, the transduction efficiency of H9C2 cell line was 95%, 72 hs after virus infection; compared with the lentiviral group, the HSP20 mRNA level of H9C2 cell increased significantly, cell viability and the amount of apoptotic cells decreased significantly, 72 hs after virus infection( all P 〈 0.01 ). Conclusion Overexpression of HSP20 can significantly inhibit the myocardial apoptosis induced by H2O2.
出处 《山东医药》 CAS 2012年第15期1-4,共4页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30973850 81173459) 广东省科技计划项目(2010B060500009) 广东省中医药局项目(2010065)
关键词 热休克蛋白20 细胞凋亡 氧化应激 heat shock protein 20 apoptosis oxidative stress
  • 相关文献

参考文献4

二级参考文献60

  • 1Yan-hui ZHU Xian WANG.Overexpression of heat-shock protein 20 in rat heart myogenic cells confers protection against simulated ischemia/reperfusion injury[J].Acta Pharmacologica Sinica,2005,26(9):1076-1080. 被引量:4
  • 2郭洁文,杨敏,朱剑光,邓志军.三七总皂苷对心血管作用的药理研究新进展[J].现代食品与药品杂志,2007,17(2):1-4. 被引量:42
  • 3Liu Y, Zhao H, Li H, et al. Mitochondfial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries [J]. Circ Res, 2003,93 (6) : 573- 580.
  • 4Wang H, Joseph JA. Quantifying cellular oxidative stress by diehlorofluorescein assay using mieroplate reader [J]. Free Radio Biol Med, 1999,27(5-6):612-616.
  • 5Kooy NW, Royall JA, Ischirepoulos H. Oxidation of 2' 7'- dichlorofluorescin by peroxynitrite [J]. Free Radic Res, 1997, 27 (3) : 245-254.
  • 6Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies [J]. Hypertension, 2007,49(4) :717-727.
  • 7Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis [J]. Trends Cell Biol, 2000,10(9) :369- 377.
  • 8Feuerstein GZ. Apoptosis- new opportunities for novel therapeutics for heart diseases [J]. Cardiovasc Drugs Ther, 2001,15(6) :547-551.
  • 9Caroppi P, Sinibaldi F, Fiorucci L, et al. Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome c as proapoptotic protein [J]. Curr Med Chem, 2009, 16(31 ) :4058-4065.
  • 10Aikawa R, Nawano M, Gu Y, et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt [J]. Circulation, 2000,102 (23) : 2873-2879.

共引文献23

同被引文献33

  • 1Xu S, Ogura S, Chen J, et al. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers[J]. Cell Mol Life Sci, 2013, 70(16): 2859-2872.
  • 2Wang X, Khaidakov M, Ding Z, et al. Cross-talk between inflammation and angiotensin Ⅱ: studies based on direct transfection of cardiomyocytes with AT1R and AT2R eDNA [J]. Exp Biol Med (Maywood), 2012, 237(12): 1394-1401.
  • 3Sakurai K, Cominacini L, Garbin U, et al. Induction of endothelin-1 production in endothelial cells via 6o-operative action between CD40 and lectin-like oxidized LDL receptor (LOX-1) [J]. J Cardiovasc Pharmacol, 2004, 44(Suppl 1): S173-S180.
  • 4Hu C, Dandapat A, Sun L, et al. Regulation of TGFbetal-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbetal in wild-type and lox-1 knock-out mouse cardiac fibroblasts[J]. J Biol Chem, 2008, 283(16): 10226-10231.
  • 5Birks E J. Molecular changes after left ventricular assist device support for heart failure[J]. Circ Res, 2013, 113(6): 777-791.
  • 6Mitra S, Goyal T, Mehta J L. Oxidized LDL, LOX-1 and atherosclerosis[J]. Cardiovasc Drugs Ther, 2011, 25(5): 419-429.
  • 7Mitra S, Deshmukh A, Sachdeva R, et al. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy[J]. Am J Med Sci, 2011,342(2): 135-142.
  • 8Sawamura T, Kakino A, Fujita Y. LOX-I: a multiligand receptor at the crossroads of response to danger signals [J]. Curr Opin Lipidol,.
  • 9Dai Y, Su W, Ding Z, et al. Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-gamma[J]. Biochem Biophys Res Commun, 2013, 431(3): 496-500.
  • 10Zhang Z, Zhang M, Li Y, et al. Simvastatin inhibits the additive activation of ERK1/2 and proliferation of rat vascular smooth muscle ceils induced by combined mechanical stross and oxLDL through LOX-1 pathway[J]. Cell Signal, 2013, 25(1): 332-340.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部